US Stocks
/
Zymeworks Inc. Share Price
Zymeworks Inc. Share Price

Zymeworks Inc. Share Price

NASDAQ: ZYME | Small Cap
$25.80
+$0.53 (2.10%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Zymeworks Inc. Stock Performance

Open
$25.46
Prev. Close
$25.27
Circuit Range
N/A
Day Range
$25.46 - $26.33
Year Range
$16.31 - $31.20
Volume
35,257
Average Traded
$25.88

Zymeworks Inc. Share Price Today

As of 10 October 2026, Zymeworks Inc.'s share price is $25.80. The stock opened at $25.46, compared to its previous close of $25.27. During today's trading session, Zymeworks Inc.'s share price traded between $25.46 and $26.33, with an average price of $25.90. Over the past 52 weeks, the stock has recorded a high of $31.20 and a low of $16.31. In terms of performance, Zymeworks Inc.'s share price has declined by 6.44% over the last six months and is up 35.15% on a year-on-year basis.

Zymeworks Inc. Share Price Chart

$25.46$26.33
L
Show Current Price
H

Zymeworks Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.95B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.09
Revenue (TTM)
$105.97B
Return On Equity (TTM)
-186.63%
Profit Margin
-76.56%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-129.69%

Zymeworks Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$27.61$2.52$2.41$4.59
Net Profit-$19.60-$41.21-$44.16-$45.02
Net Profit Margin-70.99%-1635.32%-1832.37%-980.83%
Income ChangeN/A-110.26%-7.16%-1.95%

Zymeworks Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$412.48$76.01$76.30$105.97
Net Profit$124.34-$118.67-$122.70-$81.13
Net Profit Margin30.14%-156.12%-160.81%-76.56%
Income ChangeN/A-195.44%-3.40%33.88%

About Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Zymeworks Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$26.43
$25.85
-2.49%
Sep 2026
$29.07
$26.51
-8.57%
Aug 2026
$22.02
$29.00
+32.04%
Jul 2026
$26.18
$21.96
-16.45%
Jun 2026
$24.84
$26.29
+4.66%
May 2026
$26.97
$25.11
-8.92%
Apr 2026
$25.04
$27.57
+10.17%
Mar 2026
$22.91
$25.03
+7.29%
Feb 2026
$22.70
$23.33
+3.46%
Jan 2026
$26.04
$22.55
-14.39%
Dec 2025
$26.29
$26.34
-1.50%
Nov 2025
$18.99
$26.74
+40.07%

ZYME Share Price FAQs

What is Zymeworks Inc. share price today?

chevron-up
Zymeworks Inc. share price today is $25.80 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Zymeworks Inc. stock?

chevron-up
The 52 week high of Zymeworks Inc. stock is $31.20, while the 52 week low is $16.31 as of 10 Oct '26.

What is ZYME's market capitalisation today?

chevron-up
ZYME market capitalisation is $1.95B as of October 10, 2026, at 5:17 am IST.

What is ZYME's net income for the last quarter?

chevron-up
ZYME's net income for the last quarter is -45.02B USD.

What is the 5 year returns of ZYME?

chevron-up
The 5 year returns of ZYME is 15.96% as on 10 Oct '26.

What is the high & low stock price of ZYME today?

chevron-up
ZYME stock price hit a high of $26.33 and low of $25.46 as of 10 Oct '26.

Can I buy ZYME shares in India?

chevron-up
Yes. You can buy ZYME in India by opening an international trading account.